KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Depreciation & Amortization (CF): 2020-2025

Historic Depreciation & Amortization (CF) for Aurinia Pharmaceuticals (AUPH) over the last 5 years, with Sep 2025 value amounting to $4.9 million.

  • Aurinia Pharmaceuticals' Depreciation & Amortization (CF) fell 0.57% to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.4 million, marking a year-over-year increase of 129.19%. This contributed to the annual value of $19.4 million for FY2024, which is 66.95% up from last year.
  • Latest data reveals that Aurinia Pharmaceuticals reported Depreciation & Amortization (CF) of $4.9 million as of Q3 2025, which was up 0.02% from $4.9 million recorded in Q2 2025.
  • Aurinia Pharmaceuticals' 5-year Depreciation & Amortization (CF) high stood at $5.3 million for Q3 2023, and its period low was -$6.1 million during Q4 2023.
  • For the 3-year period, Aurinia Pharmaceuticals' Depreciation & Amortization (CF) averaged around $3.1 million, with its median value being $4.9 million (2025).
  • Data for Aurinia Pharmaceuticals' Depreciation & Amortization (CF) shows a peak YoY increase of 5,633.33% (in 2021) and a maximum YoY decrease of 7,494.44% (in 2021) over the last 5 years.
  • Over the past 5 years, Aurinia Pharmaceuticals' Depreciation & Amortization (CF) (Quarterly) stood at -$1.4 million in 2021, then tumbled by 38.04% to -$1.9 million in 2022, then plummeted by 223.16% to -$6.1 million in 2023, then skyrocketed by 179.73% to $4.9 million in 2024, then decreased by 0.57% to $4.9 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $4.9 million for Q3 2025, versus $4.9 million for Q2 2025 and $4.9 million for Q1 2025.